mabl
AI-native test automation platform with an agentic tester that autonomously creates, runs, analyzes, and maintains tests (auto-healing, 85% maintenance-reduction and 94% execution-time-reduction claims — vendor-reported, no independent benchmark).
Dimension breakdown
Score · confidenceAI-native test automation platform with an agentic tester that autonomously creates, runs, analyzes, and maintains tests (auto-healing, 85% maintenance-reduction and 94% execution-time-reduction claims — vendor-reported, no independent benchmark). The integration story now runs through the cloud MCP server: the standalone local MCP server was deprecated May 18 2026 and its local test-creation/run capability folded into the cloud MCP (no CLI install required), with a May 27 'debug from your AI coding agent' / merge-to-root-cause workflow.
F500 customers (Workday, JetBlue — 90% test-execution-time reduction — Barracuda, Charles Schwab, Chewy, DataRobot, NCR, Stack Overflow) and institutional backing (GV, Vista) provide enterprise credibility; revenue ~$17.9M (2024, +37% YoY) and headcount ~114 (Apr 2026) signal steady growth. Pricing opacity (request-a-quote only on mabl.com/pricing) and cloud-only US-data deployment remain adoption barriers.
Use cases
Not yet assessed — this section fills in as ACES research covers the tool.
Risk flags
Pricing opacity
enterpriseConditionalNo public pricing or highly opaque pricing model
Caps Enterprise / Compliance at 75
Removed when — Public pricing published with clear tier structure and no hidden costs reported
Status rationale
Tracked retained. mabl shows sustained agentic-testing capability development (Agentic Tester, Application Summaries, cloud MCP developer-loop), growing company fundamentals (headcount up, revenue +37% YoY, Gartner 4.7/5), and stable enterprise customer references. Pricing opacity, cloud-only/US-only data posture, absence of SCIM in public docs, and lack of independent benchmark validation prevent advancement to Assessed without hands-on evaluation.
Movement triggers
Upgrade if: pricing transparency improves (public self-serve tiers with $ amounts), SCIM provisioning confirmed in public docs, data residency options launched (EU/regional), HIPAA or ISO 27001 certification obtained, or hands-on validation confirms the agentic-tester / auto-healing claims. Downgrade if: GenAI-feature reliability incidents accelerate into a sustained pattern, competitive alternatives capture visible enterprise churn, development cadence slows below ~1 release/week, or pricing escalation surfaces a user-exodus signal.
Risks & limitations
Pricing Opacity
ModerateRadar cap: pricing-opacity
Integration surface
Not yet assessed — this section fills in as ACES research covers the tool.
Adoption & benchmarks
Not yet assessed — this section fills in as ACES research covers the tool.
Spotted something wrong or missing here? Suggest a change →
Per-source contributions
Click any dimension to see the underlying sources and citations.
More in this category